SG

Sunita Gandhi

Active Director Director DIN 09217267
DIN 09217267 First appointment Jun 2021 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value •••• Premium profile

About Sunita Gandhi

Data last updated:

Sunita Gandhi is a Director at Ayurgenomics Botanicals Private Limited (since 2021). The company operates in FMCG. Ayurgenomics Botanicals Private Limited reported revenue of ₹16.5 Lakh (FY 2024).

DIN 09217267
Primary Designation Director
Industry FMCG
First Appointment 26 Jun 2021
Oldest Company Age 5 yrs
Largest company Ayurgenomics Botanicals Private Limited · ₹16.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Jun 20212021₹16.5 Lakh (FY 2024)Active

Board colleagues of Sunita Gandhi

Directorship timeline

Open interactive timeline →
Ayurgenomics Botanicals Private Limited
Premium access

Shareholding and investment profile for Sunita Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Gandhi

Sunita Gandhi currently holds 1 directorship: Ayurgenomics Botanicals Private Limited (Director, since 26 Jun 2021, revenue ₹16.5 Lakh (FY 2024)).

Sunita Gandhi was first appointed on 26 Jun 2021 as Director at Ayurgenomics Botanicals Private Limited.

The current boards of Sunita Gandhi's companies include Abhimanyu Kumar Sahu (Ayurgenomics Botanicals Private Limited), Sneha Agrawal (Ayurgenomics Botanicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available